The clinical efficacy of transurethral prostate resection in patients with Benign Prostatic Hyperplasia

Abstract

Background Benign prostatic hyperplasia (BPH) is a common urological disease in middle-aged and elderly men. Currently, two surgical methods are commonly used in clinical practice: transurethral plasma resection of the prostate (TUPKEP) and transurethral resection of the prostate (TURP). However, the specific advantages and disadvantages of the two surgeries still need to be further explored. Objective This study aims to analyze the clinical efficacy of TUPKEP and TURP treatments in patients with BPH, in order to find the best surgical approach. Methods 240 patients with BPH were selected and divided into a TUPKEP group and a TURP group based on surgical methods, with 120 cases in each group. The TUPKEP group received TUPKEP, while the TURP group received TURP. Compare the therapeutic effects of two groups. Results Compared with TUPKEP group, the levels of prostate specific antigen (PSA) in the TURP group were lower (P < 0.001), and the International Erectile Function Questionnaire-5 (IIEF-5) scores were higher (P < 0.01); There was no significant difference in the incidence of complications between the two groups (P > 0.05). Conclusion Compared with TUPKEP group, TURP treatment of BPH has better clinical efficacy, and the complication rate is basically the same.